Sign in
4

Changes in Ownership

Celldex Therapeutics, Inc. Filed Acc 0001415889-24-017155

Options or other derivatives

  • Director acquired 16,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
NEIL GARRY ARTHUR Director 2024-06-13 Grant or award · Non-Qualified Stock Option (right to buy) +16,500 16,500 D
Loading xslF345X05/form4-06172024_080651.xml…